We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management... Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain. Show more
LAKE FOREST, Ill., April 03, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
LAKE FOREST, Ill., April 01, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities...
Fourth Quarter Net Product Sales $32.5 Million, Cash Flow from Operations of $5.7 Million 2024 Full Year Outlook for Net Product Sales of $110 to $125 Million, Adjusted EBITDA of $20 to $30...
In Monday’s pre-market trading, U.S. index futures are indicating a downward move, following the worst week for the Dow Jones since October. Investors are keeping an eye on the important...
The Gross Law Firm Notifies Assertio Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ASRT PR Newswire NEW YORK, March 5, 2024 NEW YORK, March 5, 2024 /PRNewswire/...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.1258 | -13.9777777778 | 0.9 | 0.91 | 0.762 | 664320 | 0.84976202 | CS |
4 | -0.2258 | -22.58 | 1 | 1.09 | 0.762 | 763050 | 0.94999806 | CS |
12 | -0.1058 | -12.0227272727 | 0.88 | 1.21 | 0.762 | 919472 | 0.94621961 | CS |
26 | -1.6458 | -68.0082644628 | 2.42 | 2.53 | 0.762 | 1236216 | 1.16401902 | CS |
52 | -5.5258 | -87.7111111111 | 6.3 | 8.01 | 0.762 | 1674415 | 3.38608084 | CS |
156 | 0.297 | 62.2380553227 | 0.4772 | 8.01 | 0.419 | 1457377 | 2.89663991 | CS |
260 | -3.8558 | -83.2786177106 | 4.63 | 10.05 | 0.33 | 2319275 | 1.68263654 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions